フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Haemonetics and CSL Plasma Announce a Long-Term Plasma Collection Software Agreement PR Newswire BRAINTREE, Mass. and BOCA RATON, Fla., March 5...
CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia CSL...
U.S. FDA Accepts for Review CSL Behring's Biologics License Application for rIX-FP for Hemophilia B Patients PR Newswire KING OF PRUSSIA, Pa...
FDA Approves New Dosing Option for CSL Behring's Hizentra® New Label Supports Individualized Therapy Through Greater Dosing Flexibility From...
CSL Behring Submits Biologics License Application for FDA Approval of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant...
CSL Issues "Our Corporate Responsibility 2014" Report Led by CSL Behring performance, the company focuses on sustainable business...
CMS Extends New Technology Add-On Payment for CSL Behring's Kcentra® Designation Helps Improve Patient Access to Kcentra in the Inpatient...
Evidence presented at the 16th Biennial Meeting of the European Society for Immunodeficiencies (ESID) Supports Individualized Dosing with...
CSL Behring Announces Winners of its 13th Annual Gettin' in the Game(SM) Junior National Championship Program JNC is the Bleeding Disorders...
CSL Behring Signs Strategic Development Agreement With Enable Injections To Market Novel New Drug Delivery Device PR Newswire KING OF PRUSSIA...
CSL to acquire Novartis' influenza vaccine business bioCSL to take on expanded role in global influenza vaccine industry PR Newswire MELBOURNE...
Plasma Donors Recognized During International Plasma Awareness Week For Helping Save Lives CSL Plasma center openings are on the rise, as is the...
CSL Behring Launches $450 Million Capacity Expansion To Meet Growing Need For Lifesaving, Life-improving Therapies Company further increases...
CSL Behring Expands Manufacturing Facility In Kankakee, Illinois To Meet Patients' Growing Needs The 140,000-square foot expansion has received...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約